FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3196353648> ?p ?o ?g. }

• W3196353648 abstract "Objective: Stage II colorectal cancer (CRC) manifests various treatment responses and outcomes. To assess the recurrence risk, we established a molecular subtype classification for stage II CRC.Methods: We developed a novel molecular subtyping clustering algorithm CRC-MSC for determining molecular subtypes in stage II CRC using only whole exome sequencing (WES). It utilized a specified distance estimate, calculated according to the shared alterations among samples. CRC-MSC was qualified for classification and risk stratification on samples from National Cancer Center (NCC) and The Cancer Genome Atlas (TCGA). To facilitate application to individual management decision, this algorithm was simplified by a decision tree classifier (CRC-MDTC). Phylogenetic analysis was conducted to clarify the mutated genes constituting the decision tree.Results: Using CRC-MSC successfully subtyped 60 stage II CRC samples from NCC into three groups, favorable prognosis (S-I), unfavorable prognosis (S-II) and intermediate (S-III) groups, which was verified in TCGA dataset. These subtypes feature unique molecular, clinicopathological phenotypes and clinical outcomes, especially immune traits.A simplified version of decision tree classifier (CRC-MDTC), TMB, PRKDA and KRAS alterations are three top classification indications, could also reliably categorize samples into three groups. It was validated in an independent cohort with an accuracy of 74.7%. CRC-MSC and CRC-MDTC were available at https://bioinfo.org/crcmsc.Conclusions: In addition to the initial risk evaluation, we developed a framework for the classification of stage II CRC subtypes based on genome profiling, which may shed new light on the management of patients with stage II CRC, especially with regarded to individualized chemotherapy and immunotherapy.Funding: This work was supported by National Program Project for Precision Medicine in NationalResearch and Development Plan of China (2016YFC0905300), and CAMS Innovation Fund forMedical Sciences (CIFMS) (2019-I2M-2-002).Declaration of Interest: None to declare. Ethical Approval: The ethical approval of this study was granted by the Institutional Review Board of Chinese Academy of Medical Sciences (CHCAMS, Beijing, China)/National Cancer Center (NCC, Beijing, China)." @default.
• W3196353648 created "2021-09-13" @default.
• W3196353648 creator A5006236886 @default.
• W3196353648 creator A5006816356 @default.
• W3196353648 creator A5009519419 @default.
• W3196353648 creator A5013967365 @default.
• W3196353648 creator A5020643904 @default.
• W3196353648 creator A5024342103 @default.
• W3196353648 creator A5025454498 @default.
• W3196353648 creator A5028309463 @default.
• W3196353648 creator A5040361329 @default.
• W3196353648 creator A5044556167 @default.
• W3196353648 creator A5046884970 @default.
• W3196353648 creator A5049115038 @default.
• W3196353648 creator A5065771969 @default.
• W3196353648 creator A5066826242 @default.
• W3196353648 creator A5075390894 @default.
• W3196353648 creator A5076290816 @default.
• W3196353648 creator A5089019310 @default.
• W3196353648 creator A5089349047 @default.
• W3196353648 creator A5089972275 @default.
• W3196353648 date "2021-01-01" @default.
• W3196353648 modified "2023-10-15" @default.
• W3196353648 title "Establishment and Validation of a Novel Promising Recurrence Prediction Molecular Subtype Classification for Patients with Stage II Colorectal Cancer" @default.
• W3196353648 cites W1949303498 @default.
• W3196353648 cites W1968097173 @default.
• W3196353648 cites W1974472970 @default.
• W3196353648 cites W1986742186 @default.
• W3196353648 cites W2001393525 @default.
• W3196353648 cites W2025476423 @default.
• W3196353648 cites W2030422625 @default.
• W3196353648 cites W2049553585 @default.
• W3196353648 cites W2088525426 @default.
• W3196353648 cites W2097960717 @default.
• W3196353648 cites W2108575656 @default.
• W3196353648 cites W2109708237 @default.
• W3196353648 cites W2138455115 @default.
• W3196353648 cites W2141768150 @default.
• W3196353648 cites W2144026118 @default.
• W3196353648 cites W2148206047 @default.
• W3196353648 cites W2152032358 @default.
• W3196353648 cites W2165389801 @default.
• W3196353648 cites W2196549479 @default.
• W3196353648 cites W2743152931 @default.
• W3196353648 cites W2783897381 @default.
• W3196353648 cites W2803164733 @default.
• W3196353648 cites W2903070445 @default.
• W3196353648 cites W2916344645 @default.
• W3196353648 cites W2922492752 @default.
• W3196353648 cites W2935729650 @default.
• W3196353648 cites W2943661770 @default.
• W3196353648 cites W2945219971 @default.
• W3196353648 cites W2952880572 @default.
• W3196353648 cites W2954549198 @default.
• W3196353648 cites W2954674882 @default.
• W3196353648 cites W2969094590 @default.
• W3196353648 cites W2979077195 @default.
• W3196353648 cites W2984963674 @default.
• W3196353648 cites W3033577212 @default.
• W3196353648 doi "https://doi.org/10.2139/ssrn.3909727" @default.
• W3196353648 hasPublicationYear "2021" @default.
• W3196353648 type Work @default.
• W3196353648 sameAs 3196353648 @default.
• W3196353648 citedByCount "0" @default.
• W3196353648 crossrefType "journal-article" @default.
• W3196353648 hasAuthorship W3196353648A5006236886 @default.
• W3196353648 hasAuthorship W3196353648A5006816356 @default.
• W3196353648 hasAuthorship W3196353648A5009519419 @default.
• W3196353648 hasAuthorship W3196353648A5013967365 @default.
• W3196353648 hasAuthorship W3196353648A5020643904 @default.
• W3196353648 hasAuthorship W3196353648A5024342103 @default.
• W3196353648 hasAuthorship W3196353648A5025454498 @default.
• W3196353648 hasAuthorship W3196353648A5028309463 @default.
• W3196353648 hasAuthorship W3196353648A5040361329 @default.
• W3196353648 hasAuthorship W3196353648A5044556167 @default.
• W3196353648 hasAuthorship W3196353648A5046884970 @default.
• W3196353648 hasAuthorship W3196353648A5049115038 @default.
• W3196353648 hasAuthorship W3196353648A5065771969 @default.
• W3196353648 hasAuthorship W3196353648A5066826242 @default.
• W3196353648 hasAuthorship W3196353648A5075390894 @default.
• W3196353648 hasAuthorship W3196353648A5076290816 @default.
• W3196353648 hasAuthorship W3196353648A5089019310 @default.
• W3196353648 hasAuthorship W3196353648A5089349047 @default.
• W3196353648 hasAuthorship W3196353648A5089972275 @default.
• W3196353648 hasConcept C121608353 @default.
• W3196353648 hasConcept C126322002 @default.
• W3196353648 hasConcept C143998085 @default.
• W3196353648 hasConcept C146357865 @default.
• W3196353648 hasConcept C151730666 @default.
• W3196353648 hasConcept C526805850 @default.
• W3196353648 hasConcept C70721500 @default.
• W3196353648 hasConcept C71924100 @default.
• W3196353648 hasConcept C86803240 @default.
• W3196353648 hasConceptScore W3196353648C121608353 @default.
• W3196353648 hasConceptScore W3196353648C126322002 @default.
• W3196353648 hasConceptScore W3196353648C143998085 @default.
• W3196353648 hasConceptScore W3196353648C146357865 @default.
• W3196353648 hasConceptScore W3196353648C151730666 @default.
• W3196353648 hasConceptScore W3196353648C526805850 @default.
• W3196353648 hasConceptScore W3196353648C70721500 @default.

• next